Better Buy: CRISPR Therapeutics vs. Intellia
These two gene-editing stocks have a lot going for them. Let's consider pipelines, partnerships, and profits to make a choice.
Editors' Picks
Sturm, Ruger Feeling the Effects of Desperate Rivals
While demand has picked up, heavy promotional activity in the industry remains a headwind.
Repligen Signals Gene Therapy Strength With 2019 Earnings Report
Guidance for 2020 appears to have spooked investors, but the bioprocess leader is on a solid long-term trajectory.
McDonald's Serving Up Fast-Food-Scented Candles
The world's biggest restaurant chain's newest product lets consumers enjoy the smell of a Quarter Pounder without the calories.
Recent articles
Domino's Fortressing Strategy Still Risky Despite Comps Beat
The pizza joint benefited from third-party food delivery apps battling one another.
The Coronavirus May Affect Social Security's COLA in 2021
Lower demand for certain goods and product scarcity could create a push-pull effect on Social Security's inflationary tether.
Texas Roadhouse Soars as Effects of Higher Minimum Wages Fade
A shaky 2019 concluded with a bang for the family steakhouse.
Comcast Seeks to Buy Vudu From Walmart
Consumers rejoice: Your digital movies may be safe after all.
Mattel's Hot Wheels Unveils RC Versions of Tesla Cybertruck
The bigger radio-controlled toy even includes a broken window sticker, just like the truck Elon Musk revealed in November.
3 Great Diabetes-Focused Stocks
According to The American Diabetes Association, every $1 in $7 spent in healthcare is spent on diabetes or its complications. We look at three companies well-positioned to capture this market.
eBay Reportedly Closer to Selling Its Classified Ads Business
Sources are starting to name specific suitors and citing potential prices, which would suggest serious discussions.
SEC Reportedly Probing Altria's $12.8 Billion Stake in E-Cigarette Maker JUUL
The federal agency is concerned that the tobacco giant failed to adequately disclose the risk it was taking with investing in JUUL.
HEXO Stock Drops Following Analyst Downgrade
The marijuana company's shares dipped by 2% after Jefferies hit it with an underperform rating.
Wells Fargo to Pay $3 Billion to Settle Fraudulent Account Scandal
The bank will avoid criminal prosecution if it abides by the terms of the settlement.
FDA Approves Esperion Therapeutics' New Cholesterol Drug
Millions of patients who don't respond well enough to statins now have another affordable alternative.
SEC Launches Probe Into Altria's Juul Investment
The companies are the subject of several investigations by government agencies and regulators.
Nasdaq Adds Marijuana Price Indexes to Its Platform
New Leaf Data Services is compiling the numbers from cannabis business entities in Canada.
3 Reasons Why Globant Stock Is Surging
These three metrics reveal the strength of the tech services organization's business model.
Why HMS Holdings Shares Fell 12% Today
The company reported fourth-quarter results that came up short.
FDA's Advisory Committee to Review Claims That GlaxoSmithKline's Trelegy Ellipta Reduces Mortality
A clinical trial suggests the COPD drug reduces the risk of death compared to GSK's older treatment, but the agency has concerns about the study's design.
Why Zix Shares Rose Today
The email security expert posted strong earnings this week.
Why Teck Resources Stock Is Tanking Today
The Canadian mining company has hit a rough patch.
Curaleaf Cleared to Open Medical Marijuana Dispensaries in Pennsylvania
The company must also support research activities after being awarded Clinical Registrant status by the state.
Hasbro and Disney Agree to Release Marvel and Star Wars Toys
The toy maker could really use a boost in sales from Baby Yoda merchandise.